WallStreetZenWallStreetZen

NYSE: LLY
Eli Lilly & Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LLY past earnings growth

How has LLY's earnings growth performed historically?
Company
1.67%
Industry
39.51%
Market
40.4%
LLY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LLY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LLY's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LLY past revenue growth

How has LLY's revenue growth performed historically?
Company
5.34%
Industry
12.36%
Market
154.86%
LLY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LLY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LLY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LLY earnings and revenue history

Current Revenue
$29.2B
Current Earnings
$6.0B
Current Profit Margin
20.6%
LLY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

LLY Return on Equity

Current Company
65.4%
Current Industry
48.8%
Current Market
-8.3%
LLY's Return on Equity (65.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LLY announces earnings.

LLY Return on Assets

Current Company
12.7%
Current Industry
11.3%
LLY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LLY Return on Capital Employed

Current Company
20.59%
Current Industry
17.8%
LLY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LLY vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LLY$29.24B$8.14B$6.03B+5.41%+25.80%
MRK$58.97B$20.62B$15.26B+8.18%+42.12%
ABBV$57.82B$25.20B$13.41B+16.22%+12.65%
PFE$99.68B$38.03B$29.77B+13.69%+26.49%
JNJ$96.04B$29.56B$19.16B+5.25%+4.53%
View Top General Drug Manufacturer Stocks

LLY earnings dates

Next earnings date
Feb 2, 2023

Eli Lilly & Co Earnings & Revenue FAQ

What were LLY's earnings last quarter?

On Invalid Date, Eli Lilly & Co (NYSE: LLY) reported Q3 2022 earnings per share (EPS) of $1.61, up 31.97% year over year. Total Eli Lilly & Co earnings for the quarter were $1.45 billion. In the same quarter last year, Eli Lilly & Co's earnings per share (EPS) was $1.22.

If you're new to stock investing, here's how to buy Eli Lilly & Co stock.

What was LLY's earnings growth in the past year?

As of Q1 2023, Eli Lilly & Co's earnings has grown 1.67% year over year. This is 37.83 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Eli Lilly & Co's earnings in the past year totalled $6.03 billion.

What is LLY's earnings date?

Eli Lilly & Co's earnings date is Invalid Date. Add LLY to your watchlist to be reminded of LLY's next earnings announcement.

What was LLY's revenue last quarter?

On Invalid Date, Eli Lilly & Co (NYSE: LLY) reported Q3 2022 revenue of $6.94 billion up 2.49% year over year. In the same quarter last year, Eli Lilly & Co's revenue was $6.77 billion.

What was LLY's revenue growth in the past year?

As of Q1 2023, Eli Lilly & Co's revenue has grown 5.34% year over year. This is 7.03 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Eli Lilly & Co's revenue in the past year totalled $29.24 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.